|
| n = 101 (100%) |
|
Patient demographics |
Age (y), median (IQR) | 60 (52–67) |
Sex, male : female (count, %) | 47 (46.5):54 (53.5) |
Body mass index (kg/m²), median (IQR) | 24.6 (21.7–27.5) |
MELD score, median (IQR) | 9 (7–14) |
eGFR <90 mL/min/1.73 m², count (%) | 18 (17.8) |
|
ALBI score (count, %) |
ALBI 1 score | 30 (29.7) |
ALBI 2 score | 46 (45.5) |
ALBI 3 score | 22 (21.8) |
Unknown | 3 (3) |
|
ASA score (count, %) |
ASA I | 2 (2) |
ASA II | 74 (73.3) |
ASA III | 25 (24.8) |
|
Past medical history |
Preoperative biliary drainage, count (%) | 29 (28.7) |
Endoscopic | 18 |
Percutaneous | 6 |
Surgical | 5 |
Previous history of cholangitis, count (%) | 8 (7.9) |
Number of RBC packs transfused†, median (IQR) | 0 (0-1) |
|
Preoperative laboratory tests |
Haemoglobin (g/L), median (IQR) | 115 (107–126) |
Platelet count (109/L), median (IQR) | 285 (242–381) |
International Normalized Ratio, median (IQR) | 1.07 (1.02–1.16) |
Prothrombin time (sec), median (IQR) | 12.9 (11.8–14.5) |
Serum total bilirubin (µmol/L), median (IQR) | 22.1 (12–101.4) |
Serum glucose (µmol/L), median (IQR) | 5.1 (4.7–5.6) |
Serum creatinine (µmol/L), median (IQR) | 55 (47–66) |
Serum albumin (g/L), median (IQR) | 37 (32–41) |
Serum CA 19-9 (IU/mL), median (IQR) | 22.2 (9.7–91.4) |
|